Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Jandik

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Tumori|May 1, 1996
Mitogen-induced lymphocyte proliferation and systemic immune activation in cancer patientsB Melichar, P Jandik, J Krejsek, et al.
Electrophoresis|September 22, 2001
Proteome study of colorectal carcinogenesisJ Stulík, L Hernychová, S Porkertová, et al.
Lancet (London, England)|April 1, 2000
Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trialJ Y Douillard, D Cunningham, A D Roth, et al.
British Journal of Cancer|September 5, 2001
Kirsten ras mutations in patients with colorectal cancer: the 'RASCAL II' studyH J Andreyev, A R Norman, D Cunningham, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Tumori|May 1, 1996
Mitogen-induced lymphocyte proliferation and systemic immune activation in cancer patientsB Melichar, P Jandik, J Krejsek, et al.
Electrophoresis|September 22, 2001
Proteome study of colorectal carcinogenesisJ Stulík, L Hernychová, S Porkertová, et al.
Lancet (London, England)|April 1, 2000
Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trialJ Y Douillard, D Cunningham, A D Roth, et al.
British Journal of Cancer|September 5, 2001
Kirsten ras mutations in patients with colorectal cancer: the 'RASCAL II' studyH J Andreyev, A R Norman, D Cunningham, et al.
Pageof 2